A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea
Top Cited Papers
Open Access
- 19 April 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-11
Abstract
The gut microbiota represents a large community of microorganisms that play an important role in immune regulation and maintenance of homeostasis. Living bacteria receive increasing interest as potential therapeutics for gut disorders, because they inhibit the colonization of pathogens and positively regulate the composition of bacteria in gut. However, these treatments are often accompanied by antibiotic administration targeting pathogens. In these cases, the efficacy of therapeutic bacteria is compromised by their susceptibility to antibiotics. Here, we demonstrate that a single-cell coating composed of tannic acids and ferric ions, referred to as ‘nanoarmor’, can protect bacteria from the action of antibiotics. The nanoarmor protects both Gram-positive and Gram-negative bacteria against six clinically relevant antibiotics. The multiple interactions between the nanoarmor and antibiotic molecules allow the antibiotics to be effectively absorbed onto the nanoarmor. Armored probiotics have shown the ability to colonize inside the gastrointestinal tracts of levofloxacin-treated rats, which significantly reduced antibiotic-associated diarrhea (AAD) resulting from the levofloxacin-treatment and improved some of the pre-inflammatory symptoms caused by AAD. This nanoarmor strategy represents a robust platform to enhance the potency of therapeutic bacteria in the gastrointestinal tracts of patients receiving antibiotics and to avoid the negative effects of antibiotics in the gastrointestinal tract.Keywords
This publication has 61 references indexed in Scilit:
- Engineering Multifunctional Capsules through the Assembly of Metal–Phenolic NetworksAngewandte Chemie International Edition, 2014
- Toward Effective Probiotics for Autism and Other Neurodevelopmental DisordersCell, 2013
- Control of pathogens and pathobionts by the gut microbiotaNature Immunology, 2013
- Probiotics for the Prevention and Treatment of Antibiotic-Associated DiarrheaJAMA, 2012
- Cyborg cells: functionalisation of living cells with polymers and nanomaterialsChemical Society Reviews, 2012
- Targeting gut microbiota in obesity: effects of prebiotics and probioticsNature Reviews Endocrinology, 2011
- Clinical use of E. coli Nissle 1917 in inflammatory bowel diseaseInflammatory Bowel Diseases, 2008
- Gut flora in health and diseaseThe Lancet, 2003
- Surface Specific Kinetics of Lipid Vesicle Adsorption Measured with a Quartz Crystal MicrobalanceBiophysical Journal, 1998
- Colonization resistanceAntimicrobial Agents and Chemotherapy, 1994